Home

Prescient Therapeutics (ASX:PTX) - TechKnow Invest Roadshow, August 2023

PUBLISHED

2023-08-16

Content

Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Author